Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Perhaps announcing some actual real significant revenue would help. We can announce all of the relationships they want but if there’s no revenue, then It’s meaningless. all we have done for the last 20 years is announce relationships with no significant revenue. Not sure why that’s so hard to figure out. Still very troubling though, an insider buys 45% of the company at $3.60 a share and this stock can barely get find its way out of the $2.25 range. Something tragically wrong here.
We don’t need any more relationships, we need customers, you know people are actually buy something.
Unfortunately we only have one institution that owns shares and that’s Maxim and they’re pretty sleazy outfit from all I can tell. They’re pretty much a pump and dump firm. We would probably be much better off if they didn’t have an investment in this company.
BIO-key management has a long-standing tradition of aligning itself with predator type institutional investors. About 10 years ago it was those institutional investors that were working hard to sink the company and nearly succeeded.
I guess the real question is who is dumping shares? I think the only one left that can dump shares are probably some of the institutional investors. I would say that any of the longtime shareholders like myself, if they haven’t sold yet, probably aren’t going to sell anytime soon so in all likelihood it Wong which I doubt or it’s other institutional investors like Maxim.
Unfortunately most investors lost confidence years ago. That’s why were still trading at the Quillivant of $.10 a share on a pre-split basis.
A few reasonably positive sounding press releases in the past couple of weeks and the stock does nothing but go lower. That tells me investors have lost all confidence.
It looks like NSSC is in play. Maybe we’ll see some consolidation in the securities industry and somebody will buy out BIO-key and integrate them and their platform.
I think I’ve seen that before so I’m not sure it’s all that unusual. I think the real telling announcement will be if they announce earning Well before the deadline. Generally they do at the last possible day but if they do it a week or two earlier that would be a very good sign.
OK, what the heck, nothing else they have done has really worked in generating significant revenue. Let’s try something new again.
An acquisition is the last thing I want to see these people do. After 18 years wasted holding an investment in this company and multiple failed attempts at either acquiring someone or partnering with someone, the net result is been nothing but a loss of lots of money. I have the best idea, why don’t they go out and sell some of what they already have.
Just because they put lipstick on this pig with two reverse splits,Let’s not lose sight of the fact that this is still a $.10 per-share stock. They have not been able to sell fingerprint biometrics in any scale and that supposedly a product that we hold the best in class. If we can’t sell that, I don’t expect them to be able to self facial recognition either. Sorry boys and girls but this company needs revenue, not more stuff they can’t sell.
What do you mean there was no money? Didn’t he exercise options at $3.60 per-share? Anytime I exercise
option I know I have to pony up with the money.
Thanks for forwarding the link, didn’t realize it was on the iHub site.
Very disappointing that we’re not able to sell anything other than stock. What happened to all the money they got when Wong bought all those shares at $3.60, did we blow through that already? It was only about a month ago wasn’t it?
Does anyone have a link to this news of a new shelf registration? I can’t seem to find anything anywhere.
Well at least one thing is for certain, BIO-key may not be able to sell any of this biometric stuff but we are certainly the best at selling more and more shares. Nothing better than more dilution for a long time shareholders.
If anyone has a link, please post it.
If this patent is what I believe it is, this could be extremely far reaching and very lucrative. I seriously wonder whether there is a tremendous opportunity for patent infringement and therefore collection of lots of royalty money.
I may be way off base in thinking patent infringement but it seems to me there were several companies out there that are doing something similar to this on their products, I believe Apple in particular. I could be wrong though.
Sounds like a very significant patent win, I guess the big question is what value does it have to the company? How to be monetize it?
Is there anyone currently infringing on this patent? Maybe Apple or Samsung, is there a royalty revenue stream here? If so maybe it’s huge.
Old man, I don’t think there’s any question that this is a viable and significant industry to invest in. I believe by metric she’ll play very large part in rolled in our society in the future. No question though, it is been a long time in coming but it will come.
I believe BIO-key has the technology and quite honestly, best in class technology at least in the FP arena. The real question is, can they establish and develop the relationship to secure the business. That is been the problem for many years, it’s not the technology, it’s developing the customer base and selling product.
Wong didn’t make the investment that he did for no reason. There’s one thing that I am convinced of, he’s not a stupid guy and he’s doing this because he knows where this company can go or at least this technology can go.There is a future here, how long will it take BIO-key to really capture it and develop it as a company. I believe this company will do quite well but I also believe Wong will take this company private at $3.60 and perhaps with some small premium on top of that at some point in time. I also believe a merger with China gold Joy. is not too far fetched. They could merge with us and utilize the NASDAQ listing.
That all sounds great – but I’ve been around here for 18 years and seen this show probably six different times. Bottom line is, they need to sell something and they need to sell a lot of it.
I know your new on the scene here having showing up only a few months ago as I recall but some of us of been here for a long time and we have been diluted by 70% and that is not easy to take. There was a day when I had 3.9 million shares of the stock, now it’s only a small fraction of that and I’ve never sold any of it. Bottom line, they need to sell this stuff they need revenues I need to work on making a profit. The best thing this company has been able to do for 18 years is sell stock not BIO-key product. They have become masters at it. As far as I’m concerned, the stock is only trading at a little over $.10 a share. That’s what a 24 to 1 reverse split.
When we have Q over Q results and revenue growth, then I’ll feel more comfortable. Until that point, this is just a one trick pony. Unfortunately I’ve seen this rodeo before, Sell something.
I don’t mean to burst your bubble Ash but debt is not the problem with BIO-key. We have solved our debt problems very effectively for the past 18 years by issuing more stock and diluting the share value, Reverse splitting the stock and illuminating debt.The real issue is sales. We need to actually sell stuff and that has been the problem for as long as I have been around.
Really boils down to reoccurring sales and orders and that is where our failing is. We secure a small order but I am hard-pressed ever see a follow up order. For this company to truly survive and thrive for that matter, we need to have a consistent Q over Q increase in sales growth.
That’s the bad news, the good news is we have an insider that has committed to buying shares at $3.60 per share. What I don’t get is why the stock can’t even get close to $3.60 a share given an insider that has put his money where his mouth is. That to me is incredibly powerful and very bullish. Unfortunately the invested community doesn’t seem to believe it.
Would have been nice to see a value for this opportunity identified. Without it, it’s a rather meaningless pressure release. Is it worth $10,000 a year or $50,000 a year?
I need to unload about a third of my position in this company in the next three weeks to take part in a pre-IPO opportunity for breakthrough cancer drug and therapy. A ground floor opportunity to be first in with a guy that’s got a proven track record of bringing successful IPOs to market. Maybe Wong will want some of my shares.
Always wanted one of those opportunities to be first in, long before the IPO opens for trading. A 10X to 20X potential should far outweigh anything BIO-key Will ever do. Can’t pass on this one.
Unfortunately no follow through from this one trick pony. Couldn’t even make it around the first turn without collapsing. In all likelihood the record number of shares traded yesterday were sold short, Most likely by matrix.
Marketing should have been prepared to put out a press release today capitalizing on the record volume and supporting the future opportunities of BIO-key while all eyes were watching this companies historic level oftrading A press release supporting the potential of BIO-key would’ve been a nice follow through.
I still believe we shouldn’t be trading anywhere‘s near this level given Wongs commitment to purchase at $3.60 a share.
I was thinking the same thing, I guess the term “long term hold“ means something very different to others.
Maybe owning this stock for 18 years isn’t considered a long-term hold, it’s now a marriage, a family member.
What happened to the long-term strategy? Of course the big question I might have to ask now is did our wonderful friends at matrix short the heck out of this thing this morning.
Nothing like true conviction.
This move should not be a surprise to anyone. I’ve been saying for months that there is no logical reason why the stock is trading for anything less than three dollars a share and probably should’ve been closer to $3.50 a share giving Wongs $3.60 commitment. If that wasn’t a clear indication that at the very least Wong was going to take this company over at $3.60 plus then somebody needed to hit you over the head with a 2 x 4. That was an obvious indicator.
I like the problem here is far more fundamental then what you’re all talking about. Product and service we are providing should be growing quarter over quarter regardless of whether we are closing these so-called big projects that continue to linger. We should be developing new customers every single week since this is new technology.
I’m going to be blunt, I think sales and marketing has failed miserably in developing our market and customer base.
I am confident that this price is ridiculously low given two factors. One is that we have an insider and executive that is more than willing and has demonstrated his ability to purchase large amounts of the stock at $3.60 a share. That’s a great thing and I’m grateful for his investment. The second is the value of this company given its tax loss carry forwards. I’ve talked about this several times and I am convinced there’s a lot of value there to accompany that ultimately acquires us. I think the tax loss carry forwards are probably not worth more than the share price is right now.
In all honesty, despite the pathetic performance of the last quarter, the stock should be trading much higher.
I suspect it’s probably less than 4 million shares in the public float at this point, That’s not a lot of shares outstanding for trading
Does anyone know how many shares are available for trading in the public float? That can’t be very many with insiders owning as much as they’re starting to buy up.
It’s about time the stock started to move. Insiders are buying millions of shares at $3.60 per-share and the general public can’t figure out that $2.25 is a screaming bargain. What’s wrong with this picture.
I don’t think insiders are exercising their opportunities to buy at $3.60 for no reason at all. They know the future is extremely bright.
That’s probably very true and accurate. I put several family members in the stock 18 years ago and I hate to say, 25% of them have passed on. The most recent with about 1 million shares just three weeks ago.
It’s hard to believe that I’ve been in the stock for 18 years and I’m still buying shares the average down.
Fortunately, the only explanation for this madness is that you can’t fix stupid.
I just don’t understand this BIO-key trading. Wong is buying as an insider at a price of $3.60 a share and we’re trading on the open market at $2.09 a share.
Adding a couple thousand more at $2.09 a few minutes ago. Not sure who the stupid ones are, those selling at $2.09 or those like me buying more shares at $2.09. Clearly, one of us must be an idiot. With an insider buying at $3.60, I can’t figure out how I’m the idiot
I believe investor should take all analyst recommendation and price target with a very serious grain of salt. That holds for Maxim as well as any other analyst and any other stock for that matter. They tend to be far too self-serving.
What I consider to be the most significant event for BIO-key at this point in time is an investor by the name of Wong is taking on a 45% interest in the company at a significant premium to the trading price of the stock. That tells me that his purchase of 1.8 million shares of BIO-key stock at $3.60 a share is the most bullish indicated we can ever have.
I for the life of me can’t figure out why the stock is trading under $3.00/share with Wong buying $3.60 a share.
Is this the first shareholder meeting company is held since having to follow NASDAQ required listing rules?
I’ll take the strategic value of china gold Joy acquiring BIO-key for the NASDAQ listing even one step further.
I have been suggesting for long time that BIO-key has a significant value in its tax loss carry forwards. I would estimate that was to be worth roughly $80 million gross but probably more like $20, million-$25 million net. Although I recognize that some of those loss carry forwards will start to drop off because of time and dating. I still say they’re quite valuable to acquiring company.
I’ve been getting information about this from some pretty savvy CPAs that work for major accounting firms. Tax accountant pros to be specific. Maybe someone else can weigh in on their thoughts on the subject.
Wong isn’t buying up the stock at a significant premium for no reason.
It could happen, wouldn’t be the first time. Several companies have used this strategy before.
I think China Gold Joy can afford to purchase a significantly larger company than that.
I strongly believe that China gold Joy / Wong Will eventually buy out and take total control of BIO-key at a price of $3.60 minimum but I’m quite certain the price will have to get bid up significantly higher to get shares from long-term holders. Perhaps closer to seven or eight dollars a share, maybe even higher.
They could use BIO-key‘s NASDAQ listing to get gold Joy listed on the NASDAQ.
My guess is the company gets bought out or acquired by china gold joy long before that.
Glad I didn’t rush to sell my shares over the past 18 years that I’ve held this investment. I think my first purchase of shares in this company was 25,000 shares in 2001@ $.71. Although that may sound good based on Friday close, keep in mind, you need to multiply that figure by 24.
I was prepared to go down with the ship if I had to but now it looks like I may be able to sore with the Eagles.
Less than 10 million shares outstanding, and an insider by the name of Wong now takes control of 45% of the company, yeah, I think we can see double digits sooner rather than later. I think they’re finally doing what they needed to do for a long time, sell something.
Wong isn’t ponying up his money for no reason, he knows what the potential is, he’s not stupid.
I still question why we trading at $2.40 when insiders are buying at $3.60.
Wong, A board member,
Insider, increases his holdings by 1.8 million shares at $3.60 per share. Why are we at $2.40??? The guy now holds 45% of the outstanding shares. What part of $3.60 is not baked into the cake at this point. I’m actually quite optimistic $3.60 will be in the rearview mirror very shortly.
Share price and volume moving up. I do believe investors are starting to finally figure it out.
$3.60 is the minimum share price of the stock at this point. Not hard to figure it out.
I’m not sure it matters much what Q1 revenues are. I remain convinced that this company should be trading at $3.60 minimum just from the fact that insiders are buying up shares of that price.
Call me stupid but I don’t think Wong exercised his options at $3.60 for no reason. I still remain a buyer at these prices even though quite honestly I don’t need any more shares, I just think they’re still too cheap
BIO-key share price still trading at close to 40% discount to announce and published insider buying of $3.60/ share.
Makes no sense at all. Way undervalued as Wong increases his ownership to 45%. What’s wrong with this picture?
There was a Time when I held about 4.9% of the outstanding but unfortunately have been reverse split down to something significantly less.
I do not understand why the stock is trading below three dollars a share considering the fact that Wong has publicly indicated and actually purchased stock at $3.60 a share. It makes absolutely no sense whatsoever.
I have been a buyer once again this morning at these levels. I think Wong commitment is so strong that at some point he will take control of the entire Company at a price no lower than $3.60 a share.
Does anybody know what Wong’s total holdings are now? I got to believe he’s approaching 45% of the outstanding. Is that close or am I way off?